Meeting
2024 ASCO Quality Care Symposium
Evaluating enrollment processes and eligibility criteria of manufacturer free-drug patient assistance programs for oral anticancer agents used in hematologic malignancies.
Authors
Benyam Muluneh
Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC
Benyam Muluneh , Angela Su
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Survivorship
Sub Track
Access to Treatment
Citation
JCO Oncol Pract 20, 2024 (suppl 10; abstr 117)
DOI
10.1200/OP.2024.20.10_suppl.117
Abstract #
117
Poster Bd #
C15
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Racial disparities in pediatric patients with acute myeloid leukemia.
First Author: Ashley Becker
Poster
2024 ASCO Annual Meeting
Caregivers and legal barriers: Navigating care of a family member diagnosed with cancer.
First Author: Krista Y. Chen
Poster
2024 ASCO Annual Meeting
Assessing survival effects of persistent poverty and payer status in non-elderly adults with lung or breast cancer.
First Author: Kirsten Yuna Eom
Poster
2024 ASCO Annual Meeting
Disparities in stereotactic radiosurgery practice patterns for treatment of brain metastases: A large national cancer database study.
First Author: Kekoa A. Taparra